|
1
|
Hollinger FB and Liang TJ: Hepatitis B
Virus. Fields Virology. 4th edition. Knipe DM, Howley PM, Griffin
DE, et al: Lippincott Williams & Wilkins; Philadelphia: pp.
2971–3036. 2001
|
|
2
|
Chisari FV and Ferrari C: Viral Hepatitis.
Viral Pathogenesis. Nathanson N, Ahmed R, Gonzales-Scarano F,
Griffin DE, Holmes KV, Murphy FA and Robinson HL: Lippincott -
Raven; Philadelphia: pp. 745–778. 1997
|
|
3
|
World Health Organization: Introduction of
hepatitis B vaccine into childhood immunization services. WHO;
Geneva: 2001
|
|
4
|
Liang X, Bi S, Yang W, Wang L, Cui G, Cui
F, Zhang Y, Liu J, Gong X, Chen Y, et al: Epidemiological
serosurvey of hepatitis B in China - declining HBV prevalence due
to hepatitis B vaccination. Vaccine. 27:6550–6557. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stoop JN, van der Laan LJ, Kuipers EJ,
Kusters JG and Janssen HL: Regulatory s contribute to the impaired
immune response in patients with chronic hepatitis B virus
infection. Hepatology. 41:771–778. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boni C, Fisicaro P, Valdatta C, Amadei B,
Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A,
Missale G, et al: Characterization of hepatitis B virus
(HBV)-specific T-cell dysfunction in chronic HBV infection. J
Virol. 81:4215–4225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sobao Y, Tomiyama H, Sugi K, Tokunaga M,
Ueno T, Saito S, Fujiyama S, Morimoto M, Tanaka K and Takiguchi M:
The role of hepatitis B virus-specific memory CD8 T cells in the
control of viral replication. J Hepatol. 36:105–115. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Busca A and Kumar A: Innate immune
responses in hepatitis B virus (HBV) infection. Virol J. 11:222014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kimura N, Toyonaga B, Yoshikai Y, Du RP
and Mak TW: Sequences and repertoire of the human T cell receptor
alpha and beta chain variable region genes in thymocytes. Eur J
Immunol. 17:375–383. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Janeway CA Jr, Travers P, Walport M and
Shlomchik MJ: Immunobiology: The Immune System In Health and
Disease. 5th edition. Garland Science; New York, NY: 2001
|
|
11
|
Marrack P, Scott-Browne JP, Dai S, Gapin L
and Kappler JW: Evolutionarily conserved amino acids that control
TCR-MHC interaction. Annu Rev Immunol. 26:171–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong Y, Tan Y and Song YG: Analysis of T
cell receptor Vβ diversity in peripheral CD4+ and
CD8+ T lymphocytes obtained from patients with chronic
severe hepatitis B. Hepat Mon. 14:e159002014. View Article : Google Scholar
|
|
13
|
Yang J, Chen J, He J, Xie Y, Zhu Y, Cao H
and Li L: Profiling the repertoire of T-cell receptor beta-chain
variable genes in peripheral blood lymphocytes from subjects who
have recovered from acute hepatitis B virus infection. Cell Mol
Immunol. 11:332–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davis MM, Boniface JJ, Reich Z, Lyons D,
Hampl J, Arden B and Chien Y: Ligand recognition by alpha beta T
cell receptors. Annu Rev Immunol. 16:523–544. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Welsh RM, Selin LK and Szomolanyi-Tsuda E:
Immunological memory to viral infections. Annu Rev Immunol.
22:711–743. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lanzavecchia A and Sallusto F: Antigen
decoding by T lymphocytes: From synapses to fate determination. Nat
Immunol. 2:487–492. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mylona EE, Mouktaroudi M, Crisan TO,
Mylona EE, Mouk-taroudi M, Crisan TO, Makri S, Pistiki A, Georgitsi
M, Savva A, Netea MG, van der Meer JW, Giamarellos-Bourboulis EJ
and Joosten LA: Enhanced interleukin-1β production of PBMCs from
patients with gout after stimulation with Toll-like receptor-2
ligands and urate crystals. Arthritis Res Ther. 14:R1582012.
View Article : Google Scholar
|
|
18
|
Krell PF, Reuther S, Fischer U, Keller T,
Weber S, Gombert M, Schuster FR, Asang C, Stepensky P, Strahm B, et
al: Next-generation-sequencing-spectratyping reveals public T-cell
receptor repertoires in pediatric very severe aplastic anemia and
identifies a β chain CDR3 sequence associated with
hepatitis-induced pathogenesis. Haematologica. 98:1388–1396. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou D, Srivastava R, Grummel V, Cepok S,
Hartung HP and Hemmer B: High throughput analysis of TCR-beta
rearrangement and gene expression in single T cells. Lab Invest.
86:314–321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El-Shabrawi M and Hassanin F: Treatment of
hepatitis B and C in children. Minerva Pediatr. 66:473–489.
2014.PubMed/NCBI
|
|
21
|
Chatterjee R and Mitra A: An overview of
effective therapies and recent advances in biomarkers for chronic
liver diseases and associated liver cancer. Int Immunopharmacol.
24:335–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Freeman AJ, Marinos G, Ffrench RA and
Lloyd AR: Immunopathogenesis of hepatitis C virus infection.
Immunol Cell Biol. 79:515–536. 2001. View Article : Google Scholar
|
|
23
|
Bauer T, Sprinzl M and Protzer U: Immune
control of hepatitis B virus. Dig Dis. 29:423–433. 2011.PubMed/NCBI
|
|
24
|
Soroosh P, Shokri F, Azizi M and
Jeddi-Tehrani M: Analysis of T-cell receptor beta chain variable
gene segment usage in healthy adult responders and nonresponders to
recombinant hepatitis B vaccine. Scand J Immunol. 57:423–431. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Soon WW, Hariharan M and Snyder MP:
High-throughput sequencing for biology and medicine. Mol Syst Biol.
9:6402013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin G, Li X, Li J, Cui H, Hou R, Zhang J,
Dong F, Liang H and Zhang K: Screening of differentially expressed
genes and predominant expression of β variable region of T cell
receptor in peripheral T cells of psoriatic patients. Eur J
Dermatol. 21:938–944. 2011.PubMed/NCBI
|
|
27
|
Marino M, Maiuri MT, Di Sante G, Scuderi
F, La Carpia F, Trakas N, Provenzano C, Zisimopoulou P, Ria F,
Tzartos SJ, et al: T cell repertoire in DQ5-positive MuSK-positive
myasthenia gravis patients. J Autoimmun. 52:113–121. 2014.
View Article : Google Scholar : PubMed/NCBI
|
